Jejuna of patients with insulin-dependent diabetes mellitus (IDDM) show signs of immune activation

Clinical and Experimental Immunology

Volumn 116, Issue 1, 1999, Pages 70-77

  Savilahti, E ^a,c   Ormala T ^a   Saukkonen, T ^a   Sandini Pohjavuori, U ^a   Kantele, J M ^a   Arato, A ^a   Ilonen, J ^b   Akerblom H K ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

4 7 Integrin; HLA class II antigens; Immunohistochemistry; Insulin dependent diabetes mellitus

Indexed keywords

HLA DQ ANTIGEN; T LYMPHOCYTE RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE BIOPSY; INTESTINE CRYPT; INTESTINE LYMPHOMA; JEJUNUM; LAMINA PROPRIA; PRIORITY JOURNAL; T LYMPHOCYTE;

DIABETES MELLITUS, TYPE 1; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DP ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INTEGRINS; INTERCELLULAR ADHESION MOLECULE-1; INTESTINAL MUCOSA; JEJUNUM; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0032956641     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00860.x     Document Type: Article

References (47)

1. 1 Chervonsky AV, Wang Y, Wong FS, Visintin I, Janeway CA, Matis LA. The role of Fas in autoimmune diabetes. Cell 1997; 89:17-24.
2. 2 Obrien RL, Born WK. Direct evidence for an immunological role of lymphocytes bearing T-cell receptor-gamma-delta. Year in Immunology 1989-90. 1990; 6:51-68.
3. 3 Stassi G, Maria RD, Trucco G, Rudert W, Testi R, Galluzzo A, Giordano C, Trucco M. Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J Exp Med 1997; 186:1193-200.
4. 4 Itoh N, Imagawa A, Hanafusa T et al. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J Exp Med 1997; 186:613-8.
5. 5 Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996; 85:291-7.
6. 6 Schloot NC, Roep BO. Islet antigen-specific T cell clones in autoimmune diabetes: from mice to men. Diabet Met Rev 1997; 13:127-38.
7. 7 Zekzer D, Wong FS, Ayalon O, Millet I, Altieri M, Shintani S, Solimena M, Sherwin RS. GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice. J Clin Invest 1998; 101:68-73.
8. 7-integrin. Diabetes 1997; 46:583-8.
9. 9 Hänninen A, Taylor C, Streeter PR, Stark LS, Sarte JM, Shizuru JA. Vascular addressins are included on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium. J Clin Invest 1993; 92:2509-15.
10. 10 Lepault F, Cagnerault M-C, Faveeuw C, Bazin H, Boitard C. Lack of L-selectin expression by cells transferring diabetes in NOD mice: insights into the mechanisms involved in diabetes prevention by Mel-14 antibody treatment. Eur J Immunol 1995; 25:1502-7.
11. 11 Fabien N, Bergerot I, Orgiazzi J, Thivolet C. Lymphocyte function associated antigen-1, integrin α4, and L-selectin mediate T-cell homing to the pancreas in the model of adoptive transfer of diabetes in NOD mice. Diabetes 1996; 45:1181-6.
12. 12 Hänninen A, Salmi M, Simell O, Jalkanen S. Mucosa-associated (β7-integrin high) lymphocytes accumulate early in the pancreas of NOD mice and show aberrant recirculation behavior. Diabetes 1996; 45:1173-80.
13. 13 Vaarala O, Klemetti P, Savilahti E, Reijonen H, Honen J, Åkerblom HK. Cellular immune response to cow milk betalactoglobulin in patients with newly diagnosed insulin dependent diabetes. Diabetes 1996; 45:178-82.
14. 14 Dahlquist G, Frisk G, Ivarsson S, Svanberg L, Forsgren M, Diderholm H. Indications that maternal coxsackie B virus infection during pregnancy is a risk factor for childhood-onset IDDM. Diabetologia 1995; 38:1371-3.
15. 15 Hyöty H, Hiltunen M, Knip M et al. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes 1995; 44:652-7.
16. 16 Serreze DV, Chapman HD, Varnum DS et al. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new 'speed congenic' stock of NOD.Ig mu null mice. J Exp Med 1996; 184:2049-53.
17. 17 Noorchashm H, Noorchashm N, Kern J, Rostami SY, Barker CF, Naji A. B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes 1997; 46:941-6.
18. 18 Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E et al. Epidemiology of childhood diabetes in Finland - background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992; 35:70-76.
19. 19 Saukkonen T, Savilahti E, Reijonen H, Ilonen J, Tuomilehto-Wulf E, Åkerblom HK. Coeliac disease: frequent occurrence after clinical onset of insulin dependent diabetes mellitus. Diabetic Med 1996; 13:464-70.
20. 20 Savilahti E, Arato A, Verkasalo M. Intestinal γ/δ receptor bearing T lymphocytes in celiac disease and inflammatory bowel diseases in children. Constant increase in celiac disease. Pediatr Res 1990; 28:579-81.
21. 21 Spits H, Borst J, Giphart M, Coligan J, Terhorst C, De Vries JE. HLA-DQ antigen can serve as recognition elements for human cytotoxic T lymphocytes. Eur J Immunol 1984; 14:299-304.
22. 22 Gerdes J, Lemke H, Baisch H, Wacker H-H, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki67. J Immunol 1984; 133:1710-5.
23. 23 Ilonen J, Reijonen H, Herva E et al. Rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. Diabetes Care 1996; 19:795-800.
24. 24 Scott H, Solheim BG, Brandtzaeg P, Thorsby E. HLA-DR-like antigens in the epithelium of the human small intestine. Scand J Gastroentrol 1980; 12:77-82.
25. 25 Scott H, Brandtzaeg P, Solhei BG, Thorsby E. Relations between HLA-DR-like antigens and secretory component (SC) in jejunal epithelium of patients with coeliac disease or dermatitis herpetiformis. Clin Exp Immunol 1981; 44:233-8.
26. 26 Marley NJ, Macartney JC, Ciclitira PJ. HLA-DR, DP and DQ expression in the small intestine of patients with coeliac disease. Clin Exp Immunol 1987; 70:386-93.
27. 27 Kelly J. Weir DG, Feighery C. Differential expression of HLA-DR gene products in the normal and coeliac small bowel. Tissue Antigens 1988; 29:151-60.
28. 28 Sturgess RP, Hooper LB, Spencer J, Hung CH, Nelufer JM, Ciclitira PJ. Effects of interferon-gamma and tumour necrosis factor-alpha on epithelial HLA class-II expression on jejunal mucosal biopsy specimens cultured in vitro. Scand J Gastroenterol 1992; 27:907-11.
29. 29 Terpend K, Boisgerault F, Blaton MA, Desjeux JF, Heyman M. Protein transport and processing by human HT29-19A intestinal cells: effect of interferon gamma. Gut 1998; 42:538-45.
30. 30 von Herrath MG, Oldstone MB. Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus. J Exp Med 1997; 185:531-9.
31. 31 Picker LJ. Control of lymphocyte homing. Curr Opin Immunol 1994; 6:394-406.
32. 7 on a subset of human CD4+ memory T cells with hallmarks of gut-trophism. J Immunol 1993; 151:717-29.
33. 7. Scan J Immunol 1995; 42:662-72.
34. 34 Kantele A, Kantele JM, Savilahti E, Westerholm M, Arvilommi H, Lazarovits A, Butcher CE, Mäkelä PH. Homing potentials of circulating lymphocytes in human depend on the site of activation. Oral, but not parental, typhoid vaccination induces circulating antibody-secreting cells that all bear homing receptors directing them to the gut. J Immunol 1997; 158:574-9.
35. 35 Kantele JM, Arvilommi H, Kontiainen S, Salmi M, Jalkanen S, Savilahti E, Westerholm M, Kantele A. Mucosally activated circulating human B cells in diarrhea express homing receptors directing them back to gut. Gastroenterol 1996; 110:1061-7.
36. 36 Dianzani U, Malavasi F. Lymphocyte adhesion to endothelium. Crit Rev Immunol 1995; 15:167-200.
37. 37 Ferguson A, Arranz E, Omahony S. Clinical and pathological spectrum of coeliac disease active, silent, latent, potential. Gut 1993; 34:150-1.
38. 38 Mäki M, Hällström O, Huupponen T, Vesikari T, Visakorpi JK. Increased prevalence of coeliac disease in diabetes. Arch Dis Child 1984; 59:739-42.
39. 39 Savilahti E, Simell O, Koskimies S, Rilva A, Åkerblom HK. Celiac disease in insulin-dependent diabetes mellitus. J Pediatr 1986; 108:690-3.
40. 40 Mäki M, Huupponen T, Holm K, Hällström O. Seroconversion of reticulin antibodies predicts coeliac disease in insulin dependent diabetes mellitus. Gut 1995; 36:239-42.
41. 41 Virtanen SM, Räsänen L, Mäenpää J, Åkerblom HK. Dietary survey of Finnish adolescent diabetics and non-diabetic controls. Acta Paediatr Scand 1987; 76:801-8.
42. 42 Holm K, Mäki M, Savilahti E, Lipsanen V, Laippala P, Koskimies S. Intraepithelial gammadelta T-cell-receptor lymphocytes and genetic susceptibility to coeliac disease. Lancet 1992; 339:1500-3.
43. 43 Holm K, Savilahti E, Mäki M, Koskimies S, Lipsanen V. Immunohistochemical changes in the jejunum in first degree relatives of patients with coeliac disease marker DQ genes. HLA class II antigen expression, interleukin-2 receptor positive cells and dividing crypt cells. Gut 1994; 35:55-60.
44. 44 Spencer J, Isaacson PG, Diss TC, MacDonald TT. Expression of disulfide-linked and non-disulfide-linked forms of the T cell receptor γ/δ heterodimer in human intestinal intraepithelial lymphocytes. Eur J Immunol 1989; 19:1335-8.
45. 45 Halstensen TS, Scott H, Brandtzaeg P. Intraepithelial T cells of the TcR γ/δ+CD8-and Vδ/Jδ1+ phenotypes are increased in coeliac disease. Scand J Immunol 1989; 30:665-72.
46. 46 Mäki M, Holm K, Collin P, Savilahti E. Increase of γ/δ T cell receptor bearing lymphocytes in normal small bowel mucosa in latent coeliac disease. Gut 1991; 32:1412-4.
47. 47 Collin P, Salmi O, Hällström O, Oksa H, Oksala H, Mäki M. High frequency of coeliac disease in adult patients with type-1 diabetes. Scand J Gastroenterol 1989; 24:81-84.